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Introduction: Diabetic foot ulceration is the leading cause of amputation in people with diabetes mellitus.
Peripheral vascular disease is present in the majority of patients with diabetic foot ulcers. Despite standard
treatments there exists a high amputation rate. Circulating angiogenic cells previously known as early endothelial
progenitor cells are derived from peripheral blood and support angiogenesis and vasculogenesis, providing a
potential topical treatment for non-healing diabetic foot ulcers.
Methods: A scaffold fabricated from Type 1 collagen facilitates topical cell delivery to a diabetic wound.
Osteopontin is a matricellular protein involved in wound healing and increases the angiogenic potential of
circulating angiogenic cells. A collagen scaffold seeded with circulating angiogenic cells was developed.
Subsequently the effect of autologous circulating angiogenic cells that were seeded in a collagen scaffold and
topically delivered to a hyperglycemic cutaneous wound was assessed. The alloxan-induced diabetic rabbit ear ulcer
model was used to determine healing in response to the following treatments: collagen seeded with autologous
circulating angiogenic cells exposed to osteopontin, collagen seeded with autologous circulating angiogenic cells,
collagen alone and untreated wound. Stereology was used to assess angiogenesis in wounds.
Results: The cells exposed to osteopontin and seeded on collagen increased percentage wound closure as
compared to other groups. Increased angiogenesis was observed with the treatment of collagen and collagen
seeded with circulating angiogenic cells.
Conclusions: These results demonstrate that topical treatment of full thickness cutaneous ulcers with autologous
circulating angiogenic cells increases wound healing. Cells exposed to the matricellular protein osteopontin result
in superior wound healing. The wound healing benefit is associated with a more efficient vascular network. This
topical therapy provides a potential novel therapy for the treatment of non-healing diabetic foot ulcers in humans.* Correspondence: timothy.obrien@nuigalway.ie
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Diabetic foot ulceration is the most common reason for
hospitalization in people suffering from diabetes mellitus
[1]. Despite conventional treatments, there exists a high
amputation rate. Diabetes-related lower extremity ampu-
tations arise from pre-existing ulceration in approxi-
mately 85% of cases [2]. Topical cell-based therapy
offers a potential new treatment for non-healing ulcers
and may prevent the need for amputation. Normal cuta-
neous wound healing is a complex biological response to
trauma, involving the sequential activation and integra-
tion of several biological processes [3-5]. These pro-
cesses include coagulation, inflammation, chemotaxis,
angiogenesis and tissue remodelling. There are interac-
tions of many different cell types and cytokines to allow
normal wound healing. Delayed wound healing as occurs
with diabetes mellitus results from dysregulation of this
process [6-9].
Endothelial progenitor cells (EPCs) are a recently iden-
tified cell type which promote neoangiogenesis (new
blood vessel formation arising from pre-existing blood
vessels) and neovasculogenesis (de novo blood vessel for-
mation) [10]. Circulating angiogenic cells (CACs) have
previously been described as early EPCs and are easily
isolated from the mononuclear cell fraction of peripheral
blood [11]. More specifically, CACs are low density
mononuclear cells from peripheral blood that are plated
on fibronectin in media supplemented with endothelial
growth factors and fetal calf serum. These adherent cells
promote neovascularization predominantly by paracrine
effect. CACs are defined by culture methods and stain-
ing of acetylated low-density lipoprotein and lectin. They
are isolated and cultured in the same manner as early
EPCs [12-14].
CACs have been shown to be involved in wound heal-
ing and are recruited to sites of neovascularization in
the granulation tissue, where they help release various
cytokines that facilitate wound repair [14]. In the dia-
betic state, CACs are reduced in number and function
and contribute to the poor wound healing response seen
in diabetic ulceration [15]. CACs are constantly in the
circulation and cutaneous wounding leads to increased
homing of CACs to the wound. This arises from ische-
mia induced upregulation of stromal cell-derived factor-
1α. In addition CACs are released from bone marrow in
response to wounding. This process is impaired with
diabetes [6]. Transplanting CACs into the wound has
been reported to increase recruitment of macrophages
and promote revascularization, resulting in accelerated
healing [16].
CACs are reduced in number and are dysfunctional in
those with poorly controlled diabetes as compared to
well controlled diabetes. There are a variety of factors
which lead to differing levels of CACs. These include,but are not limited to, smoking, diabetes, hypertension
and statin medication. CACs isolated from people with
diabetes demonstrate reduced angiogenic potential as
demonstrated by reduced tubule formation in the matri-
gel assay. Diabetic CACs demonstrate reduced adhesion
to matrix proteins and reduced migration [17,18]. Our
group has recently observed decreased expression of
the matricellular protein osteopontin (OPN) in CACs
from patients with type 1 diabetes mellitus in the ab-
sence of microvascular or macrovascular complications.
OPN is a secreted glycoprotein that is involved in cell
migration, cell survival, regulation of immune cell func-
tion, inhibition of calcification, control of tumor cell
phenotype and has been implicated in the process of
neovascularization in various cancer models and per-
ipheral ischemia [18].
CAC dysfunction has been reported to be reversed by
exposure to OPN. The exposure of CACs from OPN
knockout mice to recombinant OPN augments angio-
genesis in a mouse hind limb ischemia model [18]. Au-
tologous CACs can be manipulated ex vivo to augment
cellular function. After isolation and culture of CACs,
the cells which are in culture can be manipulated to aug-
ment the angiogenic potential of CACs. This provides
an attractive autologous topical therapy with CACs ex-
posed to OPN for the treatment of diabetic ulceration.
Conventional cell transplantation techniques using
systemic intravenous injection or local intradermal injec-
tion results in low cell survival. Cells when injected
intravenously typically do not track to the wound site.
They are found in the lungs, spleen and liver [19,20].
There exists a reduced blood supply to diabetic ulcers
due to peripheral vascular disease, potentially reducing
the number of transplanted cells reaching wounds from
the systemic circulation. A collagen scaffold is an effect-
ive biomaterial to topically deliver cells to a wound and
allows for sustained viability of cells in addition to main-
taining cells at the wound site. Collagen is a constituent
of the extra-cellular matrix and has been established for
tissue engineering and cell therapy. It provides support
for cell growth and attachment.
The hypothesis tested in this study was that topical ad-
ministration of autologous CACs applied to a hypergly-
cemic full thickness cutaneous ulcer enhances wound
healing. In addition to this, the pre-activation of CACs
by OPN can further enhance the wound healing process.
Methods
Collagen extraction, scaffold formation and cell seeding
Type 1 bovine collagen solution was isolated and puri-
fied as described previously [21]. A collagen sponge
was fabricated by pipetting 1 mL of 3% (weight) type 1
atelocollagen solution into 24 well tissue culture plates
(Sarstedt Ltd, Numbrecht-Rommelsdorf, Germany). This
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freeze-dryer (Ipswich, Suffolk, UK). The collagen sponge
was then washed with Hanks balanced salt solution
(Sigma-Aldrich, Arklow, Wicklow, Ireland), three washes
with 70% ethanol, two washes of sterile water (Sigma-
Aldrich, Arklow, Wicklow, Ireland), and two washes of
supplemented EBM-2 (Lonza Swords, Ireland) media.
After the washing steps the collagen scaffold was trans-
ferred to one well of a 48 well cell culture plate
(Sarstedt). This was to ensure the scaffold was occupy-
ing the base of the well. Cells were seeded by injecting
1 × 106 in 500 μl of EBM-2 using an insulin syringe
(Becton, Dickinson and Company, Oxford, UK) and
placed in an incubator for 24 hours at 37°C and 5%
CO2. The optimum time required for cell seeding on
the scaffold was assessed by measuring metabolic activ-
ity of cells at 6, 12 and 24 hours after seeding. Figure 1
presents a representative image of the cell seeded colla-
gen scaffold pre-implantation.
Assessment of metabolic activity and cell viability
The metabolic activity of cells was assessed using the ala-
marBlue® (resazurin, Invitrogen, Carlsbad, CA, USA) assay.
This assay assesses oxidation and reduction reactions in
mitochondria. When added to cell cultures, the oxidized
form of alamarBlue® enters the cytosol and is converted to
the reduced form by mitochondrial enzyme activity by
accepting electrons from NADPH, FADH, FMNH, NADHFigure 1 H & E section of rabbit CACs seeded in a collagen scaffold. I
is a control scaffold without any CACs seeded (Scale bar = 100 μm). Image C
black arrows demonstrate CACs having been seeded on the scaffold for 24 h
the scaffold. The blue arrow points to the collagen scaffold which is homoge
fold. (Scale bar = 100 μm). The surface of the scaffold to which the cells attach
that area. Image D demonstrates another area of the scaffold which is more p
the periphery of the scaffold (orange arrow). A CAC attached to the scaffold i
angiogenic cells.as well as from the cytochromes. NADH is required for
oxidative phosphorylation and ATP generation. This redox
reaction is accompanied by a change in color of the culture
medium from blue to florescent pink, which can be mea-
sured by colorimetric or fluorometric means. Experiments
were performed in triplicate. CACs were washed once with
Hanks balanced salt solution and incubated in alamarBlue®
for 24 hours. The percentage reduction in the dye was
assessed as above. This was repeated at 24, 48 and 72
hours. The absorbances of each sample were measured in
a 96-well plate at wavelengths of 550 and 595 nm using a
microplate reader. The percentage of reduced alamarBlue®
was determined as previously described [22].
In-vivo model
Eleven male New Zealand white rabbits (3 to 3.5 kg)
were used in the study. The protocol was approved
by the ethics committee of the National University of
Ireland, Galway and the study conducted under a license
granted by the Department of Health and Children,
Dublin, Ireland. Rabbits were housed in individual cages
and with a 12-hour light/dark cycle and controlled
temperature and humidity. Rabbits were fed a standard
chow and water ad libitum.
Induction of hyperglycemia
Nine rabbits were sedated with intramuscular injection
of ketamine, xylazine and acepromazine. Hair wasmage A is a view of the cell seeded scaffold (Scale bar = 1 mm). Image B
demonstrates the cell seeded scaffold treatment pre-transplantation. The
ours. CACs are blue cells, and are predominantly located on the surface of
neous in appearance. There are large pores visible in this area of the scaf-
is applied directly to the wound bed ensuring the attachment of cells in
orous collagen. This porous appearance of the scaffold was observed at
s depicted by the black arrow (Scale bar = 100 μm). CACs, circulating
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(Sigma-Aldrich) was made up in 30 mL of saline and ad-
ministered via an ear vein using an intravenous cannula
at a rate of 1.5 mL/minute. After treatment, water con-
taining glucose was provided for 24 hours to prevent
hypoglycemia in addition to provision of molasses to
the animals’ front paws to avoid hypoglycemia. Blood
glucose was checked daily from the marginal ear vein
for the first week using Accucheck® advantage strips
(Roche, Dublin, Ireland). Blood sugar levels were then
checked weekly after the blood sugar level had stabilized.
Insulin therapy was administered if the animal lost
weight and had ‘high’ glucose readings on a glucometer
(indicating blood glucose greater than 33 mmol/L), using
insulin glargine (Sanofi-Aventis, Paris, France). Two rab-
bits were not treated with alloxan and were considered
non-diabetic controls.Autologous circulating angiogenic cell isolation and
culture used for in vivo studies
Four weeks post-alloxan treatments, rabbits were anesthe-
tized using intramuscular acepromazine (0.1 mg/kg) and
inhaled isofluorane anaesthesia. A total of 10 mL/kg of
blood was withdrawn from the marginal ear artery and
collected in lithium heparin coated blood collection tubes
(BD Biosciences, Oxford, UK). CACs were then isolated as
previously described [23]. Briefly, the blood was mixed 1:1
with Hanks balanced salt solution (Sigma) and layered on
Ficoll-Paque™ PLUS (GE Healthcare, Cork, Ireland). The
sample was centrifuged and the buffy coat was removed
to isolate the peripheral blood mononuclear cells. The
cells were then washed with red cell lysis buffer (Sigma)
and subsequently with phosphate buffered saline (PBS)
and re-suspended in EBM-2 media (Lonza). The media
was complete media and supplemented with 2% fetal bo-
vine serum, hydrocortisone, fibroblast growth factor,
insulin-like growth factor-1, ascorbic acid, epidermal
growth factor and GA-1000. Cells were plated on two
wells of a fibronectin coated six-well plate (BD Biosci-
ences). After four days EBM-2 medium was changed and
recombinant OPN (Sigma-Aldrich) was added to half the
cells at a concentration of 5 μg/mL for 24 hours. The
medium was changed with no OPN added to the other
half of CACs. Cells were trypsinized with 0.25X tryp-
sin/ethylenediaminetetraacetic acid (EDTA) (Sigma).
Cell viability was assessed by trypan blue exclusion using
a hemocytometer. A total of 1 × 105 CACs was the max-
imum number of autologous CACs which were able to be
isolated from each animal. A total of 5 × 104 CACs and
5 × 104 CACs exposed to OPN were seeded in a collagen
scaffold for 24 hours as described above. The upper sur-
face of the CAC-seeded scaffold was applied to the base of
the ulcers.Surgical procedure
Six days after phlebotomy, rabbits were anesthetized
using intramuscular injection of 0.1 mL/kg xylazine and
0.12 mL/kg ketamine which is half dose analgesia. Sterile
disposable 6 mm punch biopsies (Panvet, Ireland) were
used to create two wounds on each ear. A total of four
full-thickness punch biopsy wounds were created on
each of the nine hyperglycemic animals. The wounds
were created and the dermis exposed to bare cartilage.
Each wound was treated with one of the four random-
ized treatment groups: untreated wounds, collagen scaf-
fold alone, collagen scaffold seeded with 5 × 104 CACs,
collagen scaffold seeded with 5 × 104 CACs exposed to
OPN. The wounds were covered with a polyurethane
dressing (Opsite®, Smith & Nephew, Dublin, Ireland) and
the ear was sutured and covered with adhesive dressing,
(Operfix™, Promedicare, Dublin, Ireland) until day seven
(n = 8). On day seven, rabbits were euthanized with
intravenous sodium pentobarbital (2 mL). Twenty full-
thickness punch biopsy wounds were created in two
non-diabetic animals. Five full-thickness punch biopsy
wounds were created on each ear of the two non-
diabetic animals. Figure 2 demonstrates representative
images of diabetic and non-diabetic wounds. Wounds
were covered using an adhesive dressing (Opsite®). One
hyperglycemic animal was used to detect fluorescently
labeled CACs in the wound. This animal was sacrificed
at one week.
Wound closure
At necropsy, ears were surgically removed and the
wound area was traced. Wound closure was assessed
using Formula A. The area of the wound was deter-
mined by measuring the pixels within the tracing and
was assessed by Cell B software™ (Olympus). Wound






Formula A: Percentage Wound Closure (%C): A0 is
the area of the wound at day 0 and Ai is the area of the
wound at day seven as measured by wound tracings.
Histology
The explants were cut across the midline and fixed in
10% formalin for 24 hours. The tissue was processed
and embedded in paraffin. Sections (5 μm) were taken
when the tissue was reached. Nine sections were cut
using a microtome every 150 μm into the wound for
analysis. Three sections were placed on one slide. Sec-
tions were stained with hematoxylin and eosin using
standard protocols.
Figure 2 Gross images of untreated wounds. A) Representative gross picture of diabetic wound after one week. B) Representative gross
picture of non-diabetic wound after one week. (Scalebar = millimetres).
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CM-DiI (Invitrogen) was used to fluorescently label cells
for one animal experiment. Briefly, CACs were incubated
with CM-DiI at a concentration of 4 μM for 20 minutes.
The histological sections were obtained as above and the
cells visualized using a fluorescence microscope in the
TRITC-rhodamine channel.
Wound volume
Images were obtained at 2× magnification using an inverted
microscope (Olympus BX51). The thickness of the wound
was measured from the top of the wound to the cartilage
(Figure 3A). This was performed at six arbitrary points
across the wound and an average of six readings calculated.
Cell B software was used for analysis (Olympus). For each
wound the average thickness of the wound was multiplied
by the area obtained from the tracing of the wound at day
of necropsy to calculate wound volume.
Epithelialization
Epithelialization was assessed by measuring the horizon-
tal distance between the two wound edges (Figure 3A
(A)). The wound edge was determined by a change
in thickness of the epithelium, a lack of sebaceous
glands, hair follicles and skin appendages. The length of
the newly formed epithelium was measured (Figure 3A
(B + C)) and a percentage was obtained. This was per-
formed on the first section analyzed from the center of
the wound.
Stereology
Stereology is a means of assessing tissue responses to tis-
sue constructs [24]. It allows assessment of angiogenesisin vascular beds [25]. In the present study vertical sec-
tions of the tissue were examined using a systematic ran-
dom sampling strategy to provide estimates of relevant
stereological parameters [26].
Methods used to measure the length of vessels in
three dimensions were based on the work of Gokhale
using a vertical orientation design and a cycloid test
system [27]. A series of cycloid lines were placed on
the histology sections using Image Pro® Plus software
(Figure 4). A systematic random sampling strategy was
employed throughout this study. Five fields of view
were obtained across the wound bed from one edge of
the wound to the other edge [28]. The fields were cap-
tured at 20X magnification. To ensure blood vessels
were not artefacts in tissue, fluorescence microscopy
was used to successfully identify vascular structures.
Figure 5 demonstrates blood vessel identification using
fluorescence microscopy [25].
The parameters assessed were surface density of blood
vessels, length density of blood vessels and radial diffu-
sion distance between capillaries [24,28]. The surface
density of blood vessels was calculated using Formula B
and the length of the test line was 2,400 nm. The surface
area of blood vessels was then calculated by multiplying
the surface density by wound volume. To calculate the
length density of blood vessels, a series of cycloid lines
measuring 2,240 nm in length was rotated 90 degrees
and placed on the histological section. The length dens-
ity of blood vessels was calculated using Formula C. The
total length of blood vessels in the wound was calculated
by multiplying length density by wound volume. The ra-
dial diffusion distance was calculated using Formula D.
The radial diffusion distance allows for the measurement
Figure 3 H & E section one week post treatment. A) demonstrates an example of a wound one week after CAC + collagen application. Wound
thickness was calculated by measuring six arbitrary wound thickness lengths taken from the cartilage to the wound surface and the average thickness
obtained. Percentage epithelialization is also measured (A,B,C) Scale bar = 1 millimeter. B) demonstrates one half of the wound at increased
magnification to further define the tissue architecture. The wound edge is defined by a change in thickness of the epithelium, lack of normal skin
appendages and disorganized collagenous tissue. The collagen scaffold and new granulation tissue formation is highlighted. This is the area where
neoangiogenesis and neovascularization occurs and where further stereological analysis was undertaken. C) is an example of an untreated wound.
There is decreased wound healing as evident by a wound with little epidermal tissue formation. There is less granulation tissue, angiogenesis and
collagen observed in the control wound. This is likely due to the nature of the wound creation which is a full thickness wound created with a 6 mm
diameter punch biopsy. The wound heals from the edges and this is the reason for the morphology seen in untreated wounds.
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of the efficiency of a capillary network. The smaller the
distance between blood vessels, the shorter the distance
required for nutrients to diffuse into surrounding tissues.
Blood vessel diameter was calculated using Formula E
[29]. The blood vessel diameter has been adjusted by
multiplying by a shrinkage factor (1.6) that occurs with
tissue processing.
Sv ¼ 2 ILT
Formula B: Surface Density (SV), I = number of inter-
sections with test line.
LT = Length of test line (2,400 microns)
Lv ¼ 2  ILTs
Formula C: Length Density (LV), IL = number of inter-
sections with test line.TS = thickness of the histological section (5 μm)
Rdiff ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
π  Lvp




Formula E: Blood Vessel Diameter (d) SV = surface
density, LV = length density.
Volume fractions of cells
The volume fraction of a feature within a particular refer-
ence space can be described as the proportion of space
that the feature occupies in a unit volume [28]. Inflamma-
tory cells were counted and included lymphocytes and
neutrophils. The volume fraction was determined with a
192 point grid using Image Pro® Plus software (Media
Cybernetics) (Figure 6). Neutrophils were identified as
small dense circular multi-lobed cells and lymphocytes as
Figure 4 Enumerating blood vessels using stereology. A representative image of a hematoxylin and eosin stained histological section at 20X
magnification is shown. A series of cycloid lines are electronically placed on the section. The points where the grid intersected blood vessels are
numbered on the section. Similar to Figure 3B, the part of the wound analyzed is the area where neovascularization occurs. Scalebar = 50 μm.
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fraction Vv is calculated as follows:
¼ pp
PT
Formula F: Volume fraction: Pp is the number of inter-
sections of the grid on the cell and the PT is the number
of intersection on tissue. The volume fraction was multi-
plied by wound volume.
Statistical analysis
All bar charts represent mean ± standard deviation. A
two sample t-test was used to assess the difference be-
tween healthy and diabetic wounds. A one way analysis
of variance (ANOVA) was used to assess for a difference
across groups at seven days post treatment. Differences
between individual groups were assessed using post hoc
analysis with Fisher’s test and results are reported as
95% confidence intervals. Pearson’s correlation was car-
ried out for each group between the following parame-
ters: percentage wound closure, surface area of blood
vessels, length of blood vessels and blood vessel diam-
eter. Minitab® software was used to perform statistics.
Results
In-vivo model
Animals became hyperglycemic within 48 hours and
remained hyperglycemic for the duration of the study.Insulin therapy was required for two animals. Five ani-
mals lost weight after alloxan administration ranging
from 0.1 to 0.5 kg. Two animals died due to hypergly-
cemia and are not included in the study.
Wound closure in diabetic and non-diabetic animals
Wound closure is calculated as in Formula A. As Figure 2
demonstrates, diabetic animals had significantly reduced
percentage wound closure at one-week (35.4% ± 9.1) as
compared to non-diabetic animals (54.6% ±13.6, Mean ±
standard deviation, P <0.05, analyzed by two sample t test).
This wound healing endpoint is a highly relevant measure
as it is non-invasive and readily translatable to the clinic.
Cell labeling and metabolic activity of rabbit CACs
Figure 1 highlights a representative image of the cell-
seeded collagen scaffold. The metabolic activity of the cell-
scaffold treatment was assessed. A total of 5 × 104 rabbit
CACs demonstrated metabolic activity 24 hours after seed-
ing in a collagen scaffold. This reduced to the same level as
the collagen control at 72 hours. No statistical difference in
cell viability of CACs exposed to OPN and seeded on a col-
lagen scaffold, and CACs not exposed to OPN seeded on a
collagen scaffold was observed. The cells were located at
the wound edge and in proximity to cartilage.
Percentage wound closure in treatment groups
The treatment group with CACs exposed to OPN and de-
livered using a collagen scaffold demonstrated increased
Figure 5 Identifying blood vessels using fluorescence
microscopy. A representative image of a blood vessel in a H & E
stained histological section is demonstrated. The blood vessel
appears as a red structure under fluorescence microscopy. This
technique was used to identify blood vessels in a H & E stained
histological tissue if there was a question over tissue distortion or
artifacts in a histological section appearing as a blood vessel. This
increases the accuracy of enumerating blood vessels in histological
sections. Scalebar = 30 μm.
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as compared to collagen alone and untreated wounds
(Figure 7). CACs not exposed to OPN when seeded on a
collagen scaffold demonstrated significantly increased per-
centage wound closure when compared to untreated
wounds. There was no significant difference between
wounds treated with collagen seeded with CACs and col-
lagen alone. CACs exposed to OPN and seeded on a colla-
gen scaffold did not show a significant difference in
percentage wound closure when compared to CACs
seeded on a collagen scaffold. Representative images of
the wounds in the four groups are presented in Figure 8.
Figure 3 demonstrates representative hematoxylin and
eosin stained wounds and epithelialization of ulcers.
There was no significant difference in percentage epithe-
lialization between groups. Percentage epithelialization
was assessed one week after wound creation and treat-
ment application. The four groups analyzed included un-
treated wounds or wounds treated with three other
treatments.
Wound volume, stereology and inflammation
At one-week post treatment, collagen alone has a higher
wound volume, as compared to CACs exposed to OPNand seeded in a collagen scaffold and untreated wounds.
This increased wound volume seen with collagen results
in an increased length of blood vessels in the collagen-
treated wound and increased surface area of blood ves-
sels in the collagen-treated wound (Table 1). Figure 4
demonstrates the use of a cycloid grid on a histological
section for stereological analysis. A significantly in-
creased surface density and length density, in addition to
a reduced radial diffusion distance, is noted with all
treatment groups in comparison to untreated wounds.
Blood vessels in the wounds treated with CACs exposed
to OPN have a significantly larger diameter than un-
treated wounds. Figure 5 identifies blood vessels using
florescence microscopy. This technique is used to ensure
blood vessels were successfully identified if there was
similarity in appearance to tissue artifacts.
Analyses of inflammatory cell infiltrate revealed a sig-
nificant difference between the three treatment groups
as compared to untreated wounds. Figure 6 demon-
strates the use of a grid for calculating inflammatory cell
infiltrate. The wounds treated with CACs exposed to
OPN and delivered in a collagen scaffold revealed a
trend towards reduced inflammatory cell infiltrate as
compared to wounds treated with CACs and seeded in
collagen and collagen alone (Table 1).
The relationship between the various healing pa-
rameters was assessed in the treatment groups using
Pearson’s correlations (Table 2). For wounds treated with
CACs exposed to OPN and seeded on a collagen scaffold,
blood vessel diameter, length density and radial diffusion
distance correlated with surface density. The increased
blood vessel diameter demonstrated with this treatment
correlates with surface density of blood vessels providing
further evidence of a more efficient vascular network seen
with this treatment. This highlights that the progression
of wound healing is faster than in untreated wounds
where, although there is a correlation between blood ves-
sel diameter and surface density, it is weaker than in the
CAC exposed to OPN group. Also in the untreated
wound, there is a correlation between inflammatory cell
infiltrate, length density and surface density. This indicates
that the untreated wounds are in an earlier stage of wound
healing, that is, a more inflammatory stage of wound heal-
ing. This correlation analysis indicates a more efficient
vascular network in the CAC (OPN) group.
Figure 9 demonstrates representative hematoxylin and
eosin stained histological images of the four groups ana-
lyzed, that is, untreated wound, collagen treated wound,
collagen and CAC treated wound and collagen and CAC
exposed to OPN treated wound. The blood vessels are
increased in number and diameter in wounds treated
with collagen seeded CACs exposed to OPN.
Figure 10 demonstrates representative hematoxylin
and eosin stained histological images of the four groups
Figure 6 Calculating the volume fraction of inflammatory cells using a 192 point grid. A representative image of a hematoxylin and eosin
stained histological section demonstrates healing granulation tissue. This area is where neovascularization occurs. A grid is electronically
generated and placed on the section. Arrows indicate examples of inflammatory cells on intersection of the grid. Scalebar = 50 μm.
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wound, collagen and CAC treated wound and collagen
and CAC exposed to OPN treated wound) demonstrate
increased inflammatory cell infiltrate at one week when
compared to untreated wounds. More blood vessels are
evident in wounds treated with CAC (OPN) + collagen
(Figure 10C).Figure 7 Percentage wound closures as assessed using wound
tracing. To determine if there was a difference in percentage wound
closure, ANOVA was used. For the ANOVA analysis there was a significant
difference between groups (P= 0.003). The error bars represent standard
deviation. The number of wounds per group was eight (n = 8). To
determine if there was a difference between individual groups, post hoc
testing with Fisher’s test was used. The statistical results are reported as
95% confidence intervals (CI). * denotes a significant difference in wound
closure ((95% CI (14.109, 32.242)). ** denotes a significant difference in
wound closure ((95% CI (6.188, 24.321)). A significant difference is also
present when comparing wound closure between CAC+ collagen
treated wounds and untreated wounds ((95% CI (4.743, 22.877)).Discussion
Diabetic foot ulceration leads to amputation in a significant
proportion of cases. There is a critical need to create novel
treatments to prevent amputation in addition to decreasing
time to wound closure. EPCs delivered either systemically
or topically have been shown to augment wound healing in
both diabetic and non-diabetic cutaneous wound models
[15,16]. Early EPCs or CACs are decreased in number and
are dysfunctional in people with diabetes mellitus [30]. We
have shown that the exposure of CACs to OPN rescues
the angiogenic potential of OPN knockout CACs and re-
stores blood flow in limb ischemia [18]. Using this strategy
to restore the disease associated dysfunction associated
with diabetic CACs, the wound healing benefit of CACs
exposed to OPN was tested.
Collagen was used as cells topically delivered to wounds
do not remain at the wound site [31]. This research
supports previous hypotheses regarding the cutaneous
wound healing benefit of biomaterial mediated topical cell
delivery. This new paradigm in wound healing treatments
potentially increases wound healing and results in a super-
ior neovasculature for human diabetic foot ulceration.
There is no standard animal model to study diabetic
ulceration. The impaired cutaneous wound healing asso-
ciated with diabetes mellitus in humans may be due to a
large number of factors [6]. It is not possible to fully rep-
licate these factors in animal models. The hyperglycemic
rabbit ear ulcer is similar to the human diabetic foot
ulcer as it heals by epithelialization and granulation tis-
sue formation. The rabbit ear ulcer wound heals from
the wound edge. This is an advantage of the model as
Figure 8 Representative gross images of wounds. One week after treatment application, CAC (OPN) + collagen treatment reveals a smaller wound
(A) when compared to collagen alone (C) and untreated wounds (D). Representative images of wounds treated with CAC+ collagen treatment (that is, not
exposed to OPN) (B) appear smaller than wounds treated with collagen alone (C) and untreated wounds (D). However, there was no significant difference in
percentage wound closure between wounds treated with CACs + collagen (B) and wounds treated with collagen alone (C). Scale bar = 1 mm.
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http://stemcellres.com/content/4/6/158the cutaneous wounds heal with inflammatory cells infil-
trating the wound edge in addition to angiogenesis and
granulation tissue formation. This allows for assessment
of these wound healing phases at the area of the wound
where new wound healing is occurring. The use of stere-
ology allows determination of inflammatory cell infiltrate
and angiogenesis at this area of wound healing. As sev-
eral wounds can be created on each ear, the effects of
different treatments can be assessed and compared. The
rabbit ear ulcer does not heal by skin contraction. This
is advantageous over cutaneous wounds in rodents
which heal by contraction. Apart from wound contrac-
tion, the wound healing in rodents occurs by similar
mechanisms as in the diabetic rabbit ear ulcer. In ro-
dents, the measurement of percentage wound closure is
difficult, as a reduction in the size of the wound area is
due to contraction of the skin and not entirely due to in-
flammation, neoangiogenesis and granulation tissue for-
mation as is the normal paradigm in adult human
cutaneous wound healing. There are advantages to the
use of mice or rat models. These models are more
widely studied. There are more antibodies available for
rodent models and these animals are less expensive.
A unique aspect of the diabetic rabbit ear ulcer model
of cutaneous ulceration is that the wound is in closeTable 1 Stereological analysis of wounds in diabetic animals
Parameter CACs (OPN) + Colla
Wound volume (mm3) 13.2 ± 5.1*
Total volume of inflammatory cells (mm3) 2.37 ± 0.97#
Surface density of blood vessels in wound (mm-1) 22.4 ± 9.3#
Surface area of blood vessels (mm2) 306.3 ± 178
Length density of blood vessels in wound (mm-2) 6,212 ± 1,424#
Total length of blood vessels in wound (mm) 81,678 ± 35,117
Radial diffusion distance (μm) 7.29 ± 0.9#
Vessel diameter (μm) 1.8 ± 0.47#
Stereology analyzed by ANOVA followed by Fisher’s pairwise comparison, mean ± st
compared to untreated wound.proximity to the underlying cartilage. This is not identi-
cal to the human wound healing situation but does
provide a valid means for analyzing wound healing.
There is minimal adipose tissue underlying the wound
in this model. The significance of this is not clear, as the
role of adipose tissue in wound healing is not fully eluci-
dated. Adipose-derived stem cells promote wound heal-
ing and enhance the functions of keratinocytes and
dermal fibroblasts [32]. The reduced adipose tissue layer
may influence wound healing but this does not invali-
date the model. In humans, diabetic neuropathic ulcer-
ation occurs on the plantar aspect of the foot at areas of
increased pressure which has minimal adipose tissue,
highlighting a further similarity to diabetic wound heal-
ing in humans.
After five weeks of hyperglycemia, wounds were cre-
ated. One week after wound creation, percentage
wound closure was less in the diabetic animals as com-
pared to non-diabetic animals. These data validate that
the animal model represents a model of compromised
wound healing. Further endpoints including inflamma-
tory cell infiltrate and angiogenesis were not assessed
in diabetic and non-diabetic wounds. It is known that a
chronic inflammatory wound microenvironment per-
sists in the diabetic ulcer and that non-healinggen CACs + Collagen Collagen Untreated
14.1 ± 3.5 17.4 ± 3.6#* 12.03 ± 3.69
3.01 ± 1.16# 3.21 ± 0.91# 1.39 ± 0.5
21.6 ± 4.34# 25.6 ± 5.8# 11.1 ± 5
330.5 ± 20# 442 ± 112# 146 ± 116
6,534 ± 1,589# 7,575 ± 1,610# 4,116 ± 1093
90,490 ± 26,997# 131,220 ± 34,187# 49,337 ± 51595
7.16 ± 0.1# 6.56 ± 0.6# 9.05 ± 0.15
1.76 ± 0.46 1.74 ± 0.3 1.35 ± 0.38
andard deviation, n = 8, *P <0.05 compared to * in the same row, #P <0.05
Table 2 Pearson’s correlation values between wound healing parameters
CAC (OPN) + Collagen CAC + Collagen
WC I Sd Ld Rd WC I Sd Ld Rd
I −0.02 −0.63
Sd −0.14 −0.19 0.53 0.01
Ld 0.14 −0.30 0.76* −0.55 −0.05 −0.64
Rd −0.15 0.30 −0.74* −0.10 0.49 0.20 0.68 −0.98*
BVD −0.16 −0.02 0.86* 0.35 −0.33 −0.09 −0.44 −0.14 −0.76* 0.80*
Collagen No treatment
I −0.50 0.47
Sd 0.09 −0.03 0.38 0.88*
Ld −0.20 0.35 0.70* 0.37 0.75* 0.83*
Rd 0.16 −0.30 −0.72* −0.99* −0.20 −0.71* −0.75* −0.97*
BVD 0.01 −0.34 0.30 −0.34 0.36 0.30 0.58 0.75* 0.27 −0.15
Numbers in bold accompanied by an * indicate statistically significant correlation coefficients (P <0.05). BVD, blood vessel diameter; CAC, circulating angiogenic
cells seeded on a collagen scaffold; CAC (OPN), circulating angiogenic cells exposed to osteopontin and seeded on a collagen scaffold; I, inflammatory cell
infiltrate; Ld, length density of blood vessels; Rd, radial diffusion distance; Sd, surface density of blood vessels; WC, percentage wound closure.
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http://stemcellres.com/content/4/6/158ulceration is associated with an impaired vascular sup-
ply [7]. A change in the inflammatory response in cuta-
neous wounds may alter the rate of wound healing and
the difference in percentage wound closure may be at-
tributable to a difference in inflammatory responses in
diabetic and non-diabetic wounds. However, the ana-
lysis of inflammatory cell infiltrate in diabetic and non-
diabetic wounds would not affect the testing of the
main hypothesis in this study. The endpoint ofFigure 9 Representative histological Images of wounds. Hematoxylin a
shown one week after treatment. The arrows denote blood vessels. Wound
blood vessel number and diameter as compared to other groups. Collagen
blood vessel number and length when compared to untreated wounds (A
length density as represented by the relative absence of blood vessels seenpercentage wound closure in diabetic wounds at one
week is significantly less than in non-diabetic wounds,
and the preclinical model of impaired wound healing
was deemed suitably robust to assess the wound healing
effect of topically applied autologous CACs exposed to
OPN and seeded on a collagen scaffold.
Metabolic activity is the assessment of mitochondrial
activity in a cell. It reflects cellular health and cellular
viability. It refers to oxidation-reduction reactions ofnd Eosin stained histological sections in four treatment groups are
s treated with CAC (OPN) + collagen (D) demonstrated increased
(B) and CAC + collagen (C) treated wounds demonstrate increased
). Untreated wounds have a reduced blood vessel surface area and
in image A when compared to other images. Scale bar = 200 μm.
Figure 10 Representative images of inflammatory cell infiltrate in wounds. Representative images of hematoxylin and eosin stained
histological sections from four treatment groups one week after treatment application are presented. The cells with dark stained nuclei represent
neutrophils, macrophages and lymphocytes. Wounds treated with collagen (A) and CACs + collagen (B) reveal increased inflammatory infiltrate in
comparison to control wounds (D). Wounds treated with CAC (OPN) + collagen (C) have increased inflammatory cells when compared to control
untreated wounds (D) with the density of inflammatory cells appearing less than wounds (A) and (B), suggesting that wounds treated with CAC
(OPN) + collagen are progressing more rapidly through the stages of wound healing in comparison to wounds treated with collagen (A) and
CACs + collagen (B). This is supported by more vascular structures evident in wounds treated with CAC (OPN) + collagen (C) as compared to
other treatment groups. Scale bar = 200 μm. CAC, circulating angiogenic cells; OPN, osteopontin.
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http://stemcellres.com/content/4/6/158the electron transport chain in mitochondria. Increased
metabolic activity signifies increased cellular health and
viability. AlamarBlue® monitors the reducing environ-
ment of the living cell by measuring these oxidation-
reduction reactions. An increase in metabolic activity
indicates an increase in the activity of the electron
transport chain in mitochondria and therefore, an in-
crease in metabolic activity in a cell [33,34]. Rabbit
CACs seeded on a collagen scaffold demonstrated in-
creased metabolic activity pre-transplantation. This in-
creased metabolic activity is in comparison to control
scaffold which did not demonstrate any increased meta-
bolic activity. This result demonstrates that the isola-
tion and seeding of the collagen scaffold protocols used
are effective and result in viable cells being transplanted
to a wound.
Florescently labeled rabbit CACs seeded in a collagen
scaffold were identified in the wound one week after
treatment. The metabolic activity of 5 × 104 CACs re-
duced to control levels by 72 hours in vitro. The detec-
tion of cells in the wound after one week ensures the
collagen effectively mediates cell delivery to the wound.
Topical CAC therapy was investigated on wounds
created after five weeks of hyperglycemia. Autologous
CACs were successfully isolated from peripheral blood
of hyperglycemic rabbits and cells were exposed to OPNex vivo. These cells were then topically re-administered
to a full thickness cutaneous ulcer via a collagen scaf-
fold. The treatment group with CACs exposed to OPN
and delivered using a collagen scaffold demonstrated in-
creased percentage wound closure at one week post
treatment as compared to collagen alone and untreated
wounds. Percentage wound closure is a clinically rele-
vant endpoint in wound healing research and a wound
that closes more quickly is a goal for assessment of
wound healing treatment efficacy. This was not observed
in wounds treated with collagen and CACs not exposed
to OPN. This highlights the crucial role of pretreatment
of cells with the matricellular protein OPN in order to
achieve an increased wound healing response.
Stereology is a robust scientific tool for determining
angiogenesis and tissue responses to tissue engineered
constructs in vivo. An extensive analysis was performed
through one half of each wound at 150 micrometer in-
tervals. The beneficial increase in percentage wound
closure is not fully explained by an increase in the angio-
genesis endpoints of length density and surface density
of blood vessels. A significantly increased surface density
and length density, in addition to a reduced radial diffu-
sion distance, is noted with all treatment groups in com-
parison to untreated wounds (Table 1). It can be
concluded that angiogenesis is supported in the three
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servations that type 1 collagen is known to support
angiogenesis [35]. As the current methodology is an ex-
tensive analysis through the wound this is regarded as a
representative sample from wounds. Blood vessels in the
wounds treated with CACs exposed to OPN have a sig-
nificantly larger diameter than untreated wounds sug-
gesting a more accelerated wound healing response with
more mature blood vessels.
Analyses carried out for inflammatory cell infiltrate re-
vealed a significant difference between the three treat-
ment groups as compared to untreated wounds. The
wounds treated with CACs exposed to OPN and deliv-
ered in a collagen scaffold revealed a trend to a reduced
inflammatory cell infiltrate as compared to wounds
treated with CACs and seeded in collagen and collagen
alone (Figure 10). In addition, there are more vascular
structures evident in wounds treated with CACs exposed
to OPN and delivered in a collagen scaffold (Figure 9D).
This result highlights a potentially reduced inflammatory
environment and more mature vasculature in wounds
treated with CACs exposed to OPN. This response is
beneficial as non-healing diabetic ulcers are associated
with an increased inflammatory cell environment [7].
The initial stages of wound healing are characterized
predominantly by inflammation and immature blood ves-
sels. As normal adult wound healing progresses through
successive phases, the wound tissue comprises of a re-
duced inflammatory environment and a more mature vas-
culature. It can be hypothesized that treatment of wounds
with CACs exposed to OPN and seeded on a collagen
scaffold accelerates the normal wound healing response
and may release the diabetic ulcer from an abnormal
wound healing paradigm to a more physiological
phenotype.
Conclusions
In conclusion, an animal model of impaired wound heal-
ing in diabetes is described. The hyperglycemic rabbit
ear ulcer model investigated is a valid preclinical model
for assessing the effect of topical therapies using the end
point of wound closure. This is a model which more
closely resembles the human condition in comparison to
other rodent models. Extensive histological analysis pro-
vides insight into the neovasculature in healing wounds.
This investigative approach is relevant as a central
pathological process in non-healing diabetic ulceration is
impaired vascular supply. Subsequently, a scaffold based
cell transfer system is demonstrated. The cell scaffold
treatment approach allows for ex vivo manipulation of
autologous cells in addition to successfully mediating
cell delivery to a wound. The treatment demonstrates re-
tention of metabolic activity of cells and positioning of
cells at the wound site. Finally, this treatment results inaugmented healing with OPN-modified CACs seeded on
collagen in comparison to other groups. It is shown that
all collagen groups had increased angiogenesis. However,
treatment of collagen seeded with CACs exposed to
OPN results in a more efficient neovasculature and evi-
dence of more fully healed wounds.
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